InspireMD director buys 15,000 shares in open market
InspireMD, Inc. director Paul Stuka reported open-market purchases of the company’s common stock.
Rhea-AI Filing Summary
InspireMD, Inc. director Paul Stuka reported open-market purchases of the company’s common stock. He bought 10,000 shares on May 13, 2026 at $1.1575 per share and 5,000 shares on May 14, 2026 at $1.1500 per share, for a total of 15,000 shares.
After these direct purchases, he directly owned 647,871 shares. An additional 423,704 shares are held indirectly through Osiris Investment Partners, L.P.; the filing states no transaction occurred in those indirect holdings and that they are included for informational purposes, with beneficial ownership disclaimed except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 5,000 | $1.15 | $6K |
| Purchase | Common Stock | 10,000 | $1.1575 | $12K |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.1550 to $1.1599. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- F2. These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Key Figures
Key Terms
open-market purchase financial
weighted average price financial
beneficially own financial
pecuniary interest financial
Section 16 regulatory
FAQ
What insider transactions did InspireMD (NSPR) director Paul Stuka report?
AI-generated analysis. How Rhea-AI works. Not financial advice.